Researchers are exploring the potential of targeting cytokine and chemokine signaling pathways as a therapeutic approach for cancer. Studies are investigating the complex roles of these pathways in various types of cancer, including colorectal cancer, and their interactions with the immune system. Different strategies, such as engineered cell therapy and synthetic protein delivery systems, are being investigated for their potential to enhance antitumor responses.